GSK3B and breast cancer: MiR-1229 upregulation promoted cell proliferation in breast cancer both in vitro and in vivo, and activated Wnt/β-catenin signaling by directly targeting GSK-3β, APC, and inhibitor of β-catenin and T cell factor (ICAT).